Zhenghong (Alex) Fu

Title

GUMC Adjunct -- Associate Professor

Department

Population Sciences
General profile

Phone

+1 202-687-0862

Bio

Dr. Fu is a health services researcher and health economist, currently an Associate Professor within Department of Oncology at Georgetown University Medical Center. Prior to joining the faculty at Georgetown University in 2012, he was an assistant then an associate faculty member at Cleveland Clinic Department of Quantitative Health Sciences, and Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He received his PhD degree in Pharmaceutical Outcomes and Policy from the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy.

Dr. Fu’s primary research interests are comparative effectiveness and cost-effectiveness research, especially by using large observational datasets. The core focus of his work is to investigate which treatments work best, for whom, under what circumstances, and with greatest cost-effectiveness. The results can assist consumers, clinicians, purchasers, and policy makers to make more informed decisions about health care at both individual and population levels. He enjoys applying as well as improving the cutting-edge research methodologies in health outcomes research with experience in many chronic disease conditions.

Dr. Fu is an investigator on a list of NIH supported studies. He has been a member of Agency for Healthcare Research and Quality (AHRQ) study section, and has been on various scientific committees of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) since 2005. He currently serves as a Co-Editor for the ISPOR official journal Value in Health and on the editorial board for Journal of Medical Economics. He has published more than 70 peer-reviewed articles, commentaries, and book chapters, and his articles appear in scientific journals such as Journal of Clinical Oncology, Diabetes Care, Journal of Health Economics, Medical Decision Making, and Medical Care.

Education

  • Ph.D. (2005) University of North Carolina at Chapel Hill, Pharmaceutical Outcomes and Policy
  • B.S. (1999) Peking University, China, Cell Biology and Genetics